The first severe COVID-19 patient successfully treated with human recombinant soluble ACE2 (hrsACE2), with disappearance of coronavirus swiftly from the serum, nasal cavity and lungs, and a reduction of inflammatory cytokine levels, leading to a significant clinical improvement.
No comments:
Post a Comment